103 related articles for article (PubMed ID: 6257786)
21. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
22. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
[TBL] [Abstract][Full Text] [Related]
23. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
Tsuchiyama L; Kieran J; Boyle P; Wetzel GD
Hum Antibodies; 1997; 8(1):43-7. PubMed ID: 9265505
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.
Clave E; Agbalika F; Bajzik V; Peffault de Latour R; Trillard M; Rabian C; Scieux C; Devergie A; Socié G; Ribaud P; Adès L; Ferry C; Gluckman E; Charron D; Esperou H; Toubert A; Moins-Teisserenc H
Transplantation; 2004 Jan; 77(1):76-84. PubMed ID: 14724439
[TBL] [Abstract][Full Text] [Related]
25. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.
Chapman AL; Rickinson AB; Thomas WA; Jarrett RF; Crocker J; Lee SP
Cancer Res; 2001 Aug; 61(16):6219-26. PubMed ID: 11507075
[TBL] [Abstract][Full Text] [Related]
27. [Influence of selenium-rich rice on transformation of umbilical blood B lymphocytes by Epstein-Barr virus and Epstein-Barr virus early antigen expression].
Jian SW; Mei CE; Liang YN; Li D; Chen QL; Luo HL; Li YQ; Cai TY
Ai Zheng; 2003 Jan; 22(1):26-9. PubMed ID: 12561431
[TBL] [Abstract][Full Text] [Related]
28. EBV-transformation of surface IgA-positive human lymphocytes.
Steinitz M; Klein G
J Immunol; 1980 Jul; 125(1):194-6. PubMed ID: 6247394
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody to the Epstein-Barr virus receptor induces human B lymphocyte activation and differentiation.
Nemerow GR; McNaughton ME; Cooper NR
Trans Assoc Am Physicians; 1985; 98():290-300. PubMed ID: 3022444
[No Abstract] [Full Text] [Related]
30. Bone marrow-derived lymphoid cell lines from patients with agammaglobulinemia.
Schwaber J; Lazarus H; Rosen FS
J Clin Invest; 1978 Aug; 62(2):302-10. PubMed ID: 209061
[TBL] [Abstract][Full Text] [Related]
31. Deficiency of Epstein-Barr virus (EBV) receptors on B lymphocytes from certain patients with common varied agammaglobulinemia.
Schwaber JF; Klein G; Ernberg I; Rosen A; Lazarus H; Rosen FS
J Immunol; 1980 May; 124(5):2191-6. PubMed ID: 6245136
[No Abstract] [Full Text] [Related]
32. Epstein-Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytes.
Sauvageau G; Stocco R; Kasparian S; Menezes J
J Gen Virol; 1990 Feb; 71 ( Pt 2)():379-86. PubMed ID: 2155291
[TBL] [Abstract][Full Text] [Related]
33. Self-reactive B lymphocytes detected in young adults, children and newborns after in vitro infection with Epstein-Barr virus.
Uhlig H; Rutter G; Dernick R
Clin Exp Immunol; 1985 Oct; 62(1):75-84. PubMed ID: 2998660
[TBL] [Abstract][Full Text] [Related]
34. [Immunoglobulins and sheep red cell receptors in human lymphoblastoid cell lines simultaneously carrying Epstein-Barr virus and cytomegalovirus genomes].
Bourkas AE; Okada W; Menezes J; Joncas JH
Ann Immunol (Paris); 1977; 128(1-2):215-7. PubMed ID: 192131
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Epstein-Barr virus (EBV) receptor CD21 on peripheral B lymphocytes of long-term EBV- adults.
Jabs WJ; Paulsen M; Wagner HJ; Kirchner H; Klüter H
Clin Exp Immunol; 1999 Jun; 116(3):468-73. PubMed ID: 10361236
[TBL] [Abstract][Full Text] [Related]
36. Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes.
Jondal M; Klein G
J Exp Med; 1973 Dec; 138(6):1365-78. PubMed ID: 4357682
[TBL] [Abstract][Full Text] [Related]
37. Differences in Epstein-Barr virus (EBV) receptors expression on various human lymphoid targets and their significance to EBV-cell interaction.
Stocco R; Sauvageau G; Menezes J
Virus Res; 1988 Oct; 11(3):209-25. PubMed ID: 2848382
[TBL] [Abstract][Full Text] [Related]
38. Responses of lymphocytes to Epstein-Barr virus in patients with primary immunodeficiencies.
Kondo N; Inoue R; Orii T
J Investig Allergol Clin Immunol; 1994; 4(4):182-4. PubMed ID: 7850031
[TBL] [Abstract][Full Text] [Related]
39. Transformation of nonhuman primate lymphocytes by Epstein-Barr virus.
Deinhardt F; Falk LA; Wolfe LG
Cancer Res; 1974 May; 34(5):1241-4. PubMed ID: 4367158
[No Abstract] [Full Text] [Related]
40. In vitro stimulation of lymphocytes of donors seronegative for Epstein-Barr virus by preparations of inactivated Epstein-Barr virus.
Chang RS; Spina CA
J Infect Dis; 1976 Jun; 133(6):676-80. PubMed ID: 180190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
